Trial intelligence / Profile preview

Luteal Phase Support After GnRHa Trigger

NCT01504139Phase 4Completed

Sponsor
Regionshospitalet
Start
Jan 2012
Primary completion
Apr 2014
Modality
rProtein (Recombinant Protein), Hormone, Biologic
Countries
1
01

Overview

A Phase 4 trial of recombinant human chorionic gonadotrophin in infertility, sponsored by Regionshospitalet. Started Jan 2012; status: completed.

02

Drugs

recombinant human chorionic gonadotrophin
03

Conditions

infertility

Beyond the preview

Go deeper on NCT01504139.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01504139.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call